Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-linked agammaglobulinemia. by Fu, SM et al.
UCSF
UC San Francisco Previously Published Works
Title
Pre-B cells and other possible precursor lymphoid cell lines derived from patients with X-
linked agammaglobulinemia.
Permalink
https://escholarship.org/uc/item/4557m2zk
Journal
The Journal of experimental medicine, 152(6)
ISSN
0022-1007
Authors
Fu, SM
Hurley, JN
McCune, JM
et al.
Publication Date
1980-12-01
DOI
10.1084/jem.152.6.1519
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
PRE-B  CELLS  AND OTHER POSSIBLE  PRECURSOR 
LYMPHOID CELL  L INES DERIVED FROM PAT IENTS WITH 
X-L INKED AGAMMAGLOBUL INEMIA*  
By S. M. FU,~: J. N. HURLEY, J. M. McCUNE, H. G. KUNKEL, AND R. A. GOOD 
The Rockefeller University; and The Memorial Sloan-Kettering Cancer Center, New York 10021 
X-l inked agammaglobul inemia is characterized in the majority of the cases by the 
absence of lymphocytes bearing surface immunoglobul in  (sIg+) 1 from peripheral 
blood, in addit ion to a marked decrease of serum Ig levels (1-3). Recently, pre-B cells 
and rare sIg + B cells have been demonstrated in the bone marrow of these patients 
(4). In contrast, circulating sIg + lymphocytes are present in most cases of severe 
combined immunodeficiency (SCID) and common variable immunodeficiency 
(CVID) (4-7). 
Epstein-Barr virus (EBV)-transformed lymphoblastoid lines have been obtained 
readily in our laboratory from peripheral blood of normal individuals as well as SCID 
and CVID patients. Repeated attempts to obtain EBV-transformed cell lines from 
the blood of those with X-l inked agammaglobul inemia have not been successful. 
However, in the present study, multiple EBV-transformed cell lines were established 
from the bone marrow of three patients. Analysis of immunoglobul in  synthesis 
indicated most of these lines differed markedly from those derived from normal 
individuals, with some resembling pre-B cells, and others possible precursor cells of 
the B cell lineage. Prel iminary results have been presented previously (8). 
Mater ia l s  and  Methods  
Patients. Six cases of X-linked agammaglobulinemia were studied. The criteria for the 
diagnosis included severely depressed Ig levels, lack of sIg ÷ cells in the circulation, absence of 
specific antibodies with normal in vitro T cell responses in the mixed lymphocyte reaction and 
to phytohemagglutinin and concanavalin A, a clinical history of early onset of infection, and 
involvement of other male relatives in all cases except patient Ric., from whom no definite 
family history could be elicited. In addition, two sisters with a syndrome indistinguishable from 
X-linked agammaglobulinemia (9) were also included. Seven patients with CVID and six 
patients with SCID were studied. 
Cell Cultures and Initiation of Cell Lines. Cell cultures and initiation of cell lines were carried 
out as described previously (10). Mononuclear cells isolated by Ficoll-Hypaque gradient 
centrifugation were depleted of T cells by the sheep erythrocyte rosetting method. The non-T 
cells were then used in the initiation of cell lines. In certain cases, the non-T cells were depleted 
* Supported in part by grants RR-102, CA-24338, AI-10811, CA-19267, and AI-11843 from the U. S. 
Public Health Service, and a Basil O'Connor Starter Research grant from the National Foundation-March 
of Dimes. 
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1 CVID, common variable immunodeficiency, EAI~a, ox erythrocytes coated with IgG antibodies; EACm, 
o× erythrocytes coated with IgM antibodies and mouse complement; EBNA, Epstein-Barr viral nuclear 
antigen; EBV, Epstein-Barr virus; SDS, sodium dodecyl sulfate; mRNA, messenger RNA; SCID, severe 
combined immunodeficiency; slg,surface immunoglobulin. 
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of monocytes either by the removal of iron-ingesting cells with a magnet or by the removal of 
adherent cells. 
Immunofluorescence a d Methods for Detection of Ig Synthesis. Detection of sIg + and intracellular 
Ig and Ia antigens by 6 immunofluorescence was carried out as described (10). For internal 
labeling, cells (9 × 10/ml) were incubated with 20 #Ci/ml [aSS]methionine (700 Ci/mmol, 
New England Nuclear Inc., Boston, Mass.) in methionine-free RPMI-1640 medium that 
contained 5% dialyzed agammaglobulinemic horse serum (Grand Island Biological Co., Grand 
Island, N. Y.) for 4 h at 37°C in a 5% CO2 humidified atmosphere. After three washes, the cells 
were lysed in a buffer with 1% Triton X-100 precipitated with either affinity column-purified 
anti-p or anti-light-chain antibodies, and processed for sodium dodecyl sulfate (SDS)-po]yacryl- 
amide gel electrophoresis a previously described (1 I). 
Fc Receptors, C3 Receptors, and Other Methods. Fc receptors and C3 receptors were detected by 
a rosette formation method with either ox erythrocytes coated with IgG antibodies or IgM 
antibodies plus mouse complement, respectively, as described previously (12). The detection of 
Epstein-Barr viral nuclear antigen (EBNA) was performed as described by Reedman and Klein 
(13). 
Results 
Cell Lines from SCID and CVID Patients. The non-T fraction of the peripheral blood 
from seven patients with CVID and six patients with SCID was incubated with EBV- 
containing supernates from cell line B95-8. Within 2-4 wk, cell lines were established. 
Morphologically, these cell lines resembled those obtained from normal individuals. 
They were pleomorphic and grew as clumps in suspension. All these lines were shown 
to be EBNA positive and thus contained the EBV genome. Immunofluorescence 
analyses demonstrated that all of these lines, with one exception, synthesized both 
membrance and cytoplasmic Ig. The exceptional line had no detectable cytoplasmic 
or membrane Ig and was from an SCID patient in whom no circulating sIg + cells 
were present. 
Cell Lines from Patients with X-linked Agammaglobulinemia. Repeated attempts to 
derive cell lines with EBV preparations from the peripheral blood of six patients with 
X-linked agammaglobul inemia and two females with a syndrome clinically indistin- 
guishable from the X-linked cases were not successful. Depletion of monocytes and 
adherent cells from the non-T fraction did not help. The ages of these patients were 
8 mo (Josh), 20 yr (Ric), 21 yr (Bry), and 28 yr (Bro). 
Bone marrow aspirates were obtained from four of these patients. 11 cell lines were 
obtained from three of them. No cell lines were obtained from the oldest patient, Bro. 
In general, it took 4-6 wk to establish these lines. Except for Josh 7, supernates that 
contained EBV from cell line B95-8 were used. Josh 7 was established without the 
aid of exogenous EBV and was established 10 wk after bone marrow cells were in 
culture. 10 of the 11 cell lines had growth characteristics indistinguishable from the 
common lymphoblastoid lines. Josh 7 was unusual in that the cells were uniform and 
round. This type of unusual round cell line has been reported previously (10). 
Ig Synthesis by Cell Lines from Patients with X-Linked Agammaglobulinemia. Either a 
lack of Ig expression or unusual Ig patterns were encountered in some of these lines 
when immunofluorescence analysis was carried out (Table I). Josh 2 resembled typical 
normal lines and expressed both membrane IgM and cytoplasmic IgM with )~ light 
chain. Both/~ and )~ determinants were detected in the supernate. Josh 1 and Josh 5 
had few Ig-containing cells, although none of the cells had sIg. In the case of Josh 4, 
only cytoplasmic # chain was detected. The presence of only # chain was also found 
in the supernate of Josh 4 by both hemagglutination i hibition and immunoprecipi- 
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TABLE I 
Percentage ofCells in Different Cell Lines from Patients with X-Linked Agaramaglobulinemia Showing 
Membrane Ig and Cytoplasmic Ig as Detected by Fluorescence with Ig Antisera 
Cell lines 
Membrane lg Cytoplasmic Ig 
IgM IgG IgA K ~ IgM IgG IgA x )k 
% % 
Josh 
1 0 0 0 0 0 0* 0* 0 0 0* 
2 18 0 0 0 18 33 0 0 0 37 
3 0 0 0 0 0 0 0 0 0 0 
4 0 0 0 0 0 47 0 0 0 0 
5 0 0 0 0 0 1 0 0 2 2 
6 0 0 0 0 0 0 0 0 0 0 
7 0 0 0 0 0 0 0 0 0 0 
Ric 
1 0 0 0 0 0 45 0 0 0:~ 0 
2 0 0 0 0 0 40 0 0 0 0§ 
Bry 
1 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 0 0 
* Indicates occasional cells stained brightly, and could be identified as plasma cells. 
:~ 20% of the cells stained ully and definitely above background staining, although the staining was much 
less intense than that for IgM. 
§ 28% of the cells stained ully as those in Ric I. 
tation of [aSS]methionine-labeled chain identified by SDS gel electrophoresis. In the 
two lines from patient Ric, large numbers of  brightly stained cells were observed with 
anti-/~ antibodies. This contrasted with faint staining of lesser numbers of cells by the 
anti-light chain reagents. This finding suggested the synthesis of small amounts of 
light chain and was confirmed by biosynthetic studies involving [35S]methionine and 
gel electrophoresis. O f  five cell lines in which no Ig expression was shown by 
fluorescence, three (Josh 6, Bry 1, and Bry 2) were shown to make detectable 
amounts of heavy and light chains by biosynthetic studies. However, repeated 
experiments with [~S]methionine labeling failed to reveal any lg synthesis in either 
Josh 3 or Josh 7. 
The following represent ypical findings in the biosynthetic studies. Fig. 1 shows 
the Ig biosynthetic patterns of three cell lines from patient Josh. Anti-/x antibodies 
brought down both bt and light chains from Josh 2. In the case of Josh 3, no Ig chain 
was precipitated. From Josh 4, only labeled/~ chain was detected. To exclude the 
possibility that this chain existed in combination with unlabeled light chain formed 
prior to the [~S]methionine pulse, anti-light-chain antibodies with both K and 
specificities were used as the precipitating antibodies. These anti-light-chain antibod- 
ies brought down both # and L chains from Josh 2, but no Ig chains from either Josh 
3 or Josh 4, thus confirming the absence of light chain in Josh 4. 
Fc Receptors, C3 Receptors, and Other Studies. Ox erythrocytes coated with isolated 
IgG antibodies (EAIgG) were used to detect Fc receptors on the surface of cells. Except 
for Josh 7, 15-30% of cells formed EAtgG rosettes with eight cell lines from two 
individuals (Table II). In the case of Josh 7, 81% formed EAIgG rosettes. For C3 
receptors, EAo~ coated with IgM antibodies were incubated with a C5-deficient mouse 
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Fie. 1. Ig synthesis by three cell lines from a patient with X-linked agammaglobulinemia. Cells 
were labeled with [3SS]methionine. Triton X-100 lysates were precipitated with anti-~ antibodies. 
The immunoprecipitates were reduced and alkylated and analyzed by eleetrophoresis in 7-15~7~ 
gradient SDS-polyacrylamide gel. (a) cell line Josh 2; (b) cell line Josh 4; and (c) cell line Josh 3. 
serum to generate EACm. 83% of cells in Josh 7 formed EACr, rosettes, and 14-56% 
of cells formed EACm rosettes in the remaining cell line. In all 11 cell lines, >95% of 
the cells stained for Ia antigens and were positive for the EBNA; spontaneous sheep 
E rosettes were either absent or very rare. 
Discuss ion 
Six major types of cell lines were derived from the bone marrow of three patients 
with X-l inked agammaglobul inemia.  The first type (Josh 7) was unique in that its 
cells were round and uniform in shape. Very high percentages of the cells formed 
EAIgo and EACm rosettes. This line showed a complete absence of Ig expression and 
belongs to a group of unusual EBV that contained round cell lines reported previously 
(12). The second type (represented by Josh 3) also completely lacks Ig synthesis, 
However, it cannot be distinguished from the common B lymphoblastoid lines in cell 
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TABLE II 
Expression of Fc and (23 Receptors by Cell Lines from Patients with X-Linked 
Agammaglobulinemzh 
Cell lines Fc receptor (EAto3 C3 receptor (EACh, 
rosette-forming ceils)* rosette-forming cells)~: 
% % 
Josh 
1 28 53 
2 19 47 
3 20 14 
4 30 56 
5 15 46 
6 18 50 
7 81 83 
Ric 
1 22 33 
2 18 48 
* Fc receptors on cells were detected by a rosette formation method with ox 
erythrocytes coated with IgG antibodies. 5-60% of the cells in common EBV- 
transformed cell lines from normal individuals and patients with other 
conditions formed EAt~ rosettes. 
~: C3 receptors were detected by a rosette formation method with ox erythro- 
cytes coated with IgM antibodies and mouse complement. 30-50% of the 
cells in common EBV-transformed cell lines from other individuals formed 
EACm rosettes. 
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morphology, growth characteristics, and percentages of EAIgG and EACm rosette- 
forming cells. These two cell lines may represent transformation of B precursor cells 
at a stage before the expression of Ig. The third type (Josh 4) shows an Ig synthetic 
pattern typical ofpre-B cells (14, 15), in that only cytoplasmic ~t chain was made. The 
fourth type (Ric 1 and 2) express predominant ly  cytoplasmic /x chain with some 
cytoplasmic l ight-chain synthesis. This pattern of Ig synthesis resembles that of Nalm- 
6-M1, a leukemic cell line representing mal ignant  ransformation of B cells at a late 
pre-B cell stage (16). The fifth type (Josh 1, Josh 5, Josh 6, Bry 1, and Bry 2) showed 
synthesis of small amounts of  both heavy and light chains without the expression of  
membrane Ig. The sixth type (Josh 2) expresses both membrane and cytoplasmic bt 
and L chains, and resembles the normal lymphoblastoid lines. 
Extensive experience has accumulated in our laboratory in establishing lympho- 
blastoid lines from both normal  individuals and patients with various disorders. Over 
100 cell lines from peripheral  blood and 15 cell lines from normal bone marrow 
aspirates have been analyzed by immunofluorescence, and they were uniformly found 
to synthesize both membrane and cytoplasmic Ig. Thus, the patterns of Ig synthesis 
by most of the cell lines from X-l inked immunodefic ient patients were quite unique. 
The presence of EBNA indicates that these cell lines contain EBV genome. It 
suggests that receptors for EBV are present on some if not all B cells at developmental  
stages before sIg synthesis. Thus, like the Abelson virus in the mouse, EBV can infect 
B cells at various stages of development (15). This hypothesis is being tested by 
transformation of non-T populat ions depleted of sIg + cells from normal individuals. 
The isoiation of cell lines from patients with X- l inked agammaglobu l inemia  w s 
init ial ly undertaken in an attempt o obtain cells in culture that reflected the in vivo 
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defect in Ig synthesis. However, it is clear that at least certain of the cell lines described 
above were of the normal precursor type. This is especially evident from the various 
pre-B cell lines. It is also evident from the round cell type now obtained from 
individuals with normal Ig synthesis. Our concept at the present ime is that the other 
unique cell lines, those without any Ig synthesis, and those with very little Ig, may 
also represent precursor cell types. It became clear in this study that the absence of 
mature B cells in these patients played a major role in the isolation of the unique 
types; ordinarily, the mature B cells would be transformed and overgrow the culture 
system. Thus, it would appear that these cases represent a fertile source of material 
for studying B cell ontogeny. However, the possibility that some of the cell lines reflect 
abnormal Ig synthesis characteristic of the disease has not been ruled out. It seems 
more likely, as has been proposed before (4), that the disease results from a failure of 
terminal differentiation of normal precursor cells. 
It has become apparent hat these cell lines are of considerable value for the study 
of precursor B cells. For example, it has been demonstrated that two distinct 
translation products of human/~ chain representing the heavy chain of membrane- 
bound and secreted IgM were in cells of B lymphoblastoid lines as well as in mature 
B cells (11). Results involving in vitro translation of extracted messenger RNA 
(mRNA) from Josh 4 indicate the presence of two species of/~ chain mRNA and the 
absence of light chain mRNA. Experiments are in progress to determine whether 
these two/~ chains are analogous to those found in the more mature B cells. I f  this 
proves to be the case, it suggests that light-chain expression may play an important 
role in determining membrane/~ chain transport to the cell surface. In addition, these 
lines should prove a valuable source for the isolation of DNA in order to study the 
nature of the genes coding for Ig during the early period of human B cell development. 
The establishment of EBV-transformed lymphoblastoid lines of the normal type 
from peripheral blood of patients with CVID and SCID agrees with the results 
reported by other investigators (17-19). The lack of success in obtaining B lympho- 
blastoid lines from peripheral blood of patients with X-linked agammaglobulinemia 
is also in agreement with a previous report that, only in rare patients of X-linked 
agammaglobulinemia with circulating sIg ÷ cells, EBV-transformed lymphoblastoid 
lines were established (18). Recently, successful establishment of cell lines that 
expressed both sIg and cytoplasmic Ig from peripheral blood of the common type of 
patients was reported (19). Finally, the fact that more ceil lines were established from 
the bone marrow of the youngest patient (Josh) in the present report suggests that 
there may be more precursor B cells and some mature sIg + B cells in the bone marrow 
of patients with this disorder at an early age. There is a decline of these precursor B
cells as the patients grow older. The mechanism for this decline is not readily 
apparent. However, further documentation of this impression is needed. 
Summary  
A group of unique Epstein-Barr virus-containing cell lines was derived from the 
bone marrow of three patients with X-linked agammaglobulinemia. Efforts to obtain 
cell lines from the peripheral blood of these patients were uniformly unsuccessful. 
Immunofluorescence analyses as well as biosynthetic studies with [35S]methionine 
indicated unusual patterns of Ig synthesis in many of these bone marrow derived 
lines. Seven of the lines were of particular interest in that two produced no Ig of any 
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type; two others showed no Ig by fluorescence but small amounts by [35S]methionine 
labeling; one expressed only cytoplasmic/~ chains without any evidence of light chain 
synthesis, and two produced primarily /~ chains with only slight amounts of light 
chains. One of the lines without membrane or cytoplasmic Ig studied in detail grew 
like a typical lymphoid line and was carried in intermittent culture over a period of 
2 yr without Ig expression. One line grew quite differently and resembled the round 
cell type described previously, which has been obtained from a variety of sources. The 
cell line with cytoplasmic ~chains and no light-chain expression had the characteristic 
properties of pre-B cells. Three normal type Ig-producing cell lines also were obtained 
from the patients. 
The accumulated evidence obtained in the present study indicates that these 
unusual cell lines represent normal precursor cells of the B-cell lineage; these grew out 
in these cases because of the virtual absence of mature B cells that ordinarily overgrow 
the culture system. However, the possibility that in certain instances they reflect 
abnormal Ig synthesis characteristic of the disease has not been ruled out. 
We thank Dr. T. Hoffman, Dr. F. Siegal, Dr. S. Gupta, Dr. E. Smithwick, Dr. S. Phawa, and 
Dr. R. O'Reilly for cooperation i  patient selection. The excellent assistance of Ruth Brooks 
and Dina Rosen is appreciated. We also thank L. Light for her help in the preparation of the 
manuscript. 
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